BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25245791)

  • 21. Community-acquired pneumonia in outpatients: aetiology and outcomes.
    Cillóniz C; Ewig S; Polverino E; Marcos MA; Prina E; Sellares J; Ferrer M; Ortega M; Gabarrús A; Mensa J; Torres A
    Eur Respir J; 2012 Oct; 40(4):931-8. PubMed ID: 22267760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical response to ertapenem in severe community-acquired pneumonia: a retrospective series in an elderly population.
    Murcia JM; González-Comeche J; Marín A; Barberán J; Granizo JJ; Aguilar L; González-Moreno J; González-Pina B; López-Dupla M; Irurzun J;
    Clin Microbiol Infect; 2009 Nov; 15(11):1046-50. PubMed ID: 19548926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sputum bacteriology and antibiotic sensitivity patterns of community-acquired pneumonia in hospitalized adult patients in Nigeria: a 5-year multicentre retrospective study.
    Iroezindu MO; Chima EI; Isiguzo GC; Mbata GC; Onyedum CC; Onyedibe KI; Okoli LE
    Scand J Infect Dis; 2014 Dec; 46(12):875-87. PubMed ID: 25288384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of inhaled corticosteroids on community-acquired pneumonia in patients with bronchial asthma.
    To M; To Y; Yamada H; Ogawa C; Otomo M; Suzuki N; Sano Y
    Intern Med; 2004 Aug; 43(8):674-8. PubMed ID: 15468964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Etiology and outcome of community-acquired pneumonia in relation to age and severity in hospitalized adult patients].
    Takayanagi N; Hara K; Tokunaga D; Takaku Y; Minagawa S; Tsuchiya Y; Hijikata N; Yamaji T; Saito H; Ubukata M; Kurashima K; Yanagisawa T; Sugita Y
    Nihon Kokyuki Gakkai Zasshi; 2006 Dec; 44(12):906-15. PubMed ID: 17233386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between the use of inhaled steroids for chronic respiratory diseases and early outcomes in community-acquired pneumonia.
    Almirall J; Bolíbar I; Serra-Prat M; Palomera E; Roig J; Hospital I; Carandell E; Agustí M; Ayuso P; Estela A; Torres A;
    PLoS One; 2013; 8(9):e73271. PubMed ID: 24039899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of requirement for mechanical ventilation in community-acquired pneumonia with acute respiratory failure: a multicenter prospective study.
    Kohno S; Seki M; Takehara K; Yamada Y; Kubo K; Ishizaka A; Soma K
    Respiration; 2013; 85(1):27-35. PubMed ID: 22343936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of inhaled corticosteroids on pneumonia severity and antimicrobial resistance.
    Sibila O; Laserna E; Mortensen EM; Anzueto A; Restrepo MI
    Respir Care; 2013 Sep; 58(9):1489-94. PubMed ID: 23345471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical characteristics of community-acquired pneumonia due to Moraxella catarrhalis in adults: a retrospective single-centre study.
    Hirai J; Kinjo T; Koga T; Haranaga S; Motonaga E; Fujita J
    BMC Infect Dis; 2020 Nov; 20(1):821. PubMed ID: 33172398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes.
    Carratalà J; Mykietiuk A; Fernández-Sabé N; Suárez C; Dorca J; Verdaguer R; Manresa F; Gudiol F
    Arch Intern Med; 2007 Jul; 167(13):1393-9. PubMed ID: 17620533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes of health care-associated pneumonia empirically treated with guideline-concordant regimens versus community-acquired pneumonia guideline-concordant regimens for patients admitted to acute care wards from home.
    Chen JI; Slater LN; Kurdgelashvili G; Husain KO; Gentry CA
    Ann Pharmacother; 2013 Jan; 47(1):9-19. PubMed ID: 23324506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does prolonged onset of symptoms have a prognostic significance in community-acquired pneumonia?
    Sanz F; Restrepo MI; Fernández-Fabrellas E; Cervera A; Briones ML; Novella L; Aguar MC; Chiner E; Fernandez JF; Blanquer J
    Respirology; 2014 Oct; 19(7):1073-9. PubMed ID: 24995803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Causes and factors associated with early failure in hospitalized patients with community-acquired pneumonia.
    Rosón B; Carratalà J; Fernández-Sabé N; Tubau F; Manresa F; Gudiol F
    Arch Intern Med; 2004 Mar; 164(5):502-8. PubMed ID: 15006826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severity and outcomes of hospitalised community-acquired pneumonia in COPD patients.
    Liapikou A; Polverino E; Ewig S; Cillóniz C; Marcos MA; Mensa J; Bello S; Martin-Loeches I; Menéndez R; Torres A
    Eur Respir J; 2012 Apr; 39(4):855-61. PubMed ID: 21920895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hospitalized community-acquired pneumonia due to Streptococcus pneumoniae: Has resistance to antibiotics decreased?
    Vallès X; Marcos A; Pinart M; Piñer R; Marco F; Mensa JM; Torres A
    Chest; 2006 Sep; 130(3):800-6. PubMed ID: 16963678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Community-acquired pneumonia in the elderly: a practical guide to treatment.
    Lieberman D; Lieberman D
    Drugs Aging; 2000 Aug; 17(2):93-105. PubMed ID: 10984198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibiotic therapy prior to hospital admission is associated with reduced septic shock and need for mechanical ventilation in patients with community-acquired pneumonia.
    Amaro R; Sellarés J; Polverino E; Cillóniz C; Ferrer M; Fernández-Barat L; Mensa J; Niederman MS; Torres A
    J Infect; 2017 May; 74(5):442-449. PubMed ID: 28130142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Medical outcomes and antimicrobial compliance according to the Chilean Society of Respiratory Diseases guidelines for hospitalized patients with community acquired pneumonia].
    Díaz A; Kuzmanic G; Platzer L; Sanfuentes F; Espinoza MA; Saldías F
    Rev Med Chil; 2003 Aug; 131(8):847-56. PubMed ID: 14558238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacteraemia and antibiotic-resistant pathogens in community acquired pneumonia: risk and prognosis.
    Torres A; Cillóniz C; Ferrer M; Gabarrús A; Polverino E; Villegas S; Marco F; Mensa J; Menéndez R; Niederman M
    Eur Respir J; 2015 May; 45(5):1353-63. PubMed ID: 25614173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of the Infectious Diseases Society of America/American Thoracic Society criteria to predict severe community-acquired pneumonia caused by Streptococcus pneumoniae.
    Kontou P; Kuti JL; Nicolau DP
    Am J Emerg Med; 2009 Oct; 27(8):968-74. PubMed ID: 19857416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.